Webinar | Cut Fermentation Cost Without Sacrificing Scale-Up 15th May | 12 PM ET: Register Now

Celaid Therapeutics

Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders.
2020
1-10
Hongo, Tokyo, Japan

Investment Funding

Last Funding Stage

Early Stage Venture

Total Funding Amount

$14.6M

Last Funding Amount

$555.0M

Last Funding Date

07-10-2025

Startup Stage

Series B

Lead Investors

AMED, NEDO, UTEC - The University of Tokyo Edge Capital Partners

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information